Literature DB >> 29337966

Drug development: Allosteric inhibitors hit USP7 hard.

Wei Zhang1, Sachdev S Sidhu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29337966     DOI: 10.1038/nchembio.2557

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  11 in total

Review 1.  Modulation of the p53/MDM2 interplay by HAUSP inhibitors.

Authors:  Omid Tavana; Wei Gu
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

2.  USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.

Authors:  Alexandra Pozhidaeva; Gabrielle Valles; Feng Wang; Jian Wu; David E Sterner; Phuong Nguyen; Joseph Weinstock; K G Suresh Kumar; Jean Kanyo; Dennis Wright; Irina Bezsonova
Journal:  Cell Chem Biol       Date:  2017-10-19       Impact factor: 8.116

3.  Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.

Authors:  Wei Zhang; Maria A Sartori; Taras Makhnevych; Kelly E Federowicz; Xiaohui Dong; Li Liu; Satra Nim; Aiping Dong; Jingsong Yang; Yanjun Li; Dania Haddad; Andreas Ernst; Dirk Heerding; Yufeng Tong; Jason Moffat; Sachdev S Sidhu
Journal:  J Mol Biol       Date:  2017-06-03       Impact factor: 5.469

4.  A strategy for modulation of enzymes in the ubiquitin system.

Authors:  Andreas Ernst; George Avvakumov; Jiefei Tong; Yihui Fan; Yanling Zhao; Philipp Alberts; Avinash Persaud; John R Walker; Ana-Mirela Neculai; Dante Neculai; Andrew Vorobyov; Pankaj Garg; Linda Beatty; Pak-Kei Chan; Yu-Chi Juang; Marie-Claude Landry; Christina Yeh; Elton Zeqiraj; Konstantina Karamboulas; Abdellah Allali-Hassani; Masoud Vedadi; Mike Tyers; Jason Moffat; Frank Sicheri; Laurence Pelletier; Daniel Durocher; Brian Raught; Daniela Rotin; Jianhua Yang; Michael F Moran; Sirano Dhe-Paganon; Sachdev S Sidhu
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

5.  Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells.

Authors:  Frédéric Colland; Etienne Formstecher; Xavier Jacq; Céline Reverdy; Cécile Planquette; Susan Conrath; Virginie Trouplin; Julie Bianchi; Vasily N Aushev; Jacques Camonis; Alessandra Calabrese; Catherine Borg-Capra; Wolfgang Sippl; Vincent Collura; Guillaume Boissy; Jean-Christophe Rain; Philippe Guedat; Rémi Delansorne; Laurent Daviet
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

6.  Molecular basis of USP7 inhibition by selective small-molecule inhibitors.

Authors:  Andrew P Turnbull; Stephanos Ioannidis; Wojciech W Krajewski; Adan Pinto-Fernandez; Claire Heride; Agnes C L Martin; Louise M Tonkin; Elizabeth C Townsend; Shane M Buker; David R Lancia; Justin A Caravella; Angela V Toms; Thomas M Charlton; Johanna Lahdenranta; Erik Wilker; Bruce C Follows; Nicola J Evans; Lucy Stead; Cristina Alli; Vladislav V Zarayskiy; Adam C Talbot; Alexandre J Buckmelter; Minghua Wang; Crystal L McKinnon; Fabienne Saab; Joanna F McGouran; Hannah Century; Malte Gersch; Marc S Pittman; C Gary Marshall; Tony M Raynham; Mary Simcox; Lorna M D Stewart; Sheila B McLoughlin; Jaime A Escobedo; Kenneth W Bair; Christopher J Dinsmore; Tim R Hammonds; Sunkyu Kim; Sylvie Urbé; Michael J Clague; Benedikt M Kessler; David Komander
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

7.  Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants.

Authors:  Wei Zhang; Ben A Bailey-Elkin; Robert C M Knaap; Baldeep Khare; Tim J Dalebout; Garrett G Johnson; Puck B van Kasteren; Nigel J McLeish; Jun Gu; Wenguang He; Marjolein Kikkert; Brian L Mark; Sachdev S Sidhu
Journal:  PLoS Pathog       Date:  2017-05-18       Impact factor: 6.823

Review 8.  Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets.

Authors:  Lynn Bedford; James Lowe; Lawrence R Dick; R John Mayer; James E Brownell
Journal:  Nat Rev Drug Discov       Date:  2010-12-10       Impact factor: 84.694

9.  System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.

Authors:  Wei Zhang; Kuen-Phon Wu; Maria A Sartori; Hari B Kamadurai; Alban Ordureau; Chong Jiang; Peter Y Mercredi; Ryan Murchie; Jicheng Hu; Avinash Persaud; Manjeet Mukherjee; Nan Li; Anne Doye; John R Walker; Yi Sheng; Zhenyue Hao; Yanjun Li; Kevin R Brown; Emmanuel Lemichez; Junjie Chen; Yufeng Tong; J Wade Harper; Jason Moffat; Daniela Rotin; Brenda A Schulman; Sachdev S Sidhu
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

10.  A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants.

Authors:  Mads Gabrielsen; Lori Buetow; Mark A Nakasone; Syed Feroj Ahmed; Gary J Sibbet; Brian O Smith; Wei Zhang; Sachdev S Sidhu; Danny T Huang
Journal:  Mol Cell       Date:  2017-10-19       Impact factor: 17.970

View more
  2 in total

1.  USP7 limits CDK1 activity throughout the cell cycle.

Authors:  Antonio Galarreta; Pablo Valledor; Patricia Ubieto-Capella; Vanesa Lafarga; Eduardo Zarzuela; Javier Muñoz; Marcos Malumbres; Emilio Lecona; Oscar Fernandez-Capetillo
Journal:  EMBO J       Date:  2021-04-15       Impact factor: 14.012

Review 2.  Emerging drug development technologies targeting ubiquitination for cancer therapeutics.

Authors:  Gianluca Veggiani; María Carla Rosales Gerpe; Sachdev S Sidhu; Wei Zhang
Journal:  Pharmacol Ther       Date:  2019-03-07       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.